Professionnels de la santé – e-Learning

Learning Objectives:

• Recall updates to National Advisory Committee on Immunization (NACI) recommendations for influenza vaccination and expected changes to vaccine composition
• Describe the role of real-world evidence in clinical decision making
• Explain the association between influenza infection and cardiovascular events, loss of functional independence, and frailty in older adults
• Counsel older adults on the impact of vaccination on reducing the above risks and vaccine options indicated for this population

This continuing education is free for members of CanadianHealthcareNetwork.ca. Visit www.canadianhealthcarenetwork.ca to sign up.

Pour vous inscrire, allez au site Internet de eCortex.ca.

Learning Objectives:

At the end of this on-demand webinar, you will be able to:

• Recall updates to NACI recommendations for influenza vaccination and expected changes to vaccine composition.
• Describe the role of real-world evidence in evaluating the effectiveness of influenza vaccination in specific populations.
• Explain the association between influenza infection and cardiovascular events, loss of functional independence, and frailty in older adults.
• Describe implementation strategies to support older adult patients in the pharmacy during the busy influenza season.

Supported by educational funding from CSL Seqirus.

Pour vous inscrire, allez au site Internet de eCortex.ca.

Learning Objectives:

At the end of this on-demand webinar, you will be able to:

• Understand the burden of influenza and its consequences on the older adult population (65+ years)
• Discuss recommendations for seasonal influenza under the NACI statement for the 2024-2025 season
• Describe different influenza vaccine recommendations based on evidence-based recommendations
• Discuss best practices for influenza vaccination delivery based on age group and health outcomes using clinical/case studies

This program is an unaccredited learning activity supported by educational funding from Sanofi.

Pour vous inscrire, allez au site Internet de eCortex.ca.

This training module is intended as a refresher on how to administer the flu vaccine. The module can be completed within 30 minutes.

The iMD Patient Engagement Platform is a web-based patient education platform that is available on any device with internet. iMD Health enables healthcare providers to bring their patient sessions to life through the seamless integration of professionally-vetted diagrams, educational resources, brochures and videos covering over 1,800 medical conditions, procedures and treatment options.

To get your account, visit app.imdhealth.com/signup.

Ce programme de formation médicale continue (FMC) d’une durée de 30 minutes est agréé par le programme Mainpro+ du Collège des médecins de famille du Canada et s’adresse aux professionnels de la santé canadiens. Il a pour objectif d’offrir un enseignement sur le fardeau de la grippe chez les adultes plus âgés et sur les données cliniques qui étayent les options vaccinales destinées à cette population à risque élevé. Ce programme fournit également des informations pratiques sur les vaccins antigrippaux disponibles au Canada, leur coadministration avec d’autres vaccins et les recommandations vaccinales nationales, dans le but d’aider les cliniciens à offrir une protection optimale contre la grippe aux adultes plus âgés.

Objectifs d'apprentissage :

Après avoir complété ce programme de formation continue, le participant sera mieux en mesure de :​

• Saisir le fardeau de la grippe chez les adultes plus âgés et l’importance de la vaccination antigrippale
• Examiner les données probantes concernant la vaccination antigrippale chez les adultes plus âgés
• Appliquer les recommandations 2024-2025 du CCNI en matière de vaccination antigrippale et de coadministration avec d’autres vaccins chez les adultes plus âgés

Pour vous inscrire, allez au site Internet de mdBriefCase.

Ce programme de formation médicale continue (FMC) d’une durée de 30 minutes est agréé par le CCCEP et l’OPQ et s’adresse aux pharmaciens canadiens. Il a pour objectif d’offrir un enseignement sur le fardeau de la grippe chez les adultes plus âgés et sur les mesures de prévention et de contrôle de la grippe chez ces personnes, ainsi que les données cliniques qui appuient les options vaccinales destinées à cette population à risque élevé. Ce programme fournit également des informations pratiques sur les vaccins antigrippaux disponibles au Canada, leur coadministration avec d’autres vaccins et les recommandations vaccinales nationales, pour appuyer les discussions avec les adultes plus âgés au sujet des protections optimales disponibles pour eux.

Objectifs d'apprentissage :

Après avoir complété ce programme de formation continue, le participant sera mieux en mesure de :​

• Saisir le fardeau de la grippe chez les adultes plus âgés et l’importance de la vaccination antigrippale
• Appliquer les recommandations 2024-2025 du CCNI en matière de vaccination antigrippale et de coadministration avec d’autres vaccins chez les adultes plus âgés
• Mettre en œuvre la vaccination antigrippale en contexte de pratique clinique

Si vous êtes Pharmacien, visitez RxBriefCase pour vous inscrire.

This is a 15-minute expert brief for Canadian primary care providers and other healthcare professionals. Due to the limited therapeutic options available to manage RSV disease, the goal is to provide education on disease prevention. This expert brief is designed to provide practical information on passive immunization options available for infants in Canada, with a focus on NACI’s recommendations for the use of nirsevimab, the recently authorized long-acting monoclonal antibody. The expert brief video will feature a conversation between a Pediatric Infectious Disease Specialist and a Family Physician.

Learning objectives:
After viewing this expert brief, participants will be better able to:

• Recognize the burden of RSV disease in all infants
• Summarize NACI guidance for a universal RSV immunization program
• Implement RSV immunoprophylaxis in clinical practice

Si vous êtes Médecin/Infirmier/Spécialiste, veuillez visiter MDBriefCase pour vous inscrire.

Si vous êtes Pharmacien, visitez RxBriefCase pour vous inscrire.

Ce webinaire de 60 minutes est conçu pour offrir aux praticiens de la santé canadiens des informations pratiques sur les options d’immunisation passive pour la prévention de l’infection au VRS disponibles au Québec pour les nourrissons, mettant l’accent sur le nirsévimab, l’anticorps monoclonal à longue durée d’action récemment autorisé.

Le webinaire abordera la prévention du VRS au moyen d’études de cas et décrira comment les modèles d’ordonnance hospitaliers peuvent appuyer la mise en œuvre de la nouvelle immunoprophylaxie contre le VRS en pratique clinique.

Objectifs d'apprentissage :
Après avoir complété ce programme de formation, les participants seront mieux à même de:

• Décrire la prévalence et le fardeau de la maladie causée par le VRS chez tous les nourrissons
• Résumer les lignes directrices de l’INESSS et les données probantes à l’appui de l’immunisation passive contre le VRS
• Mettre en œuvre un modèle d’ordonnance hospitalière pour la prévention du VRS afin de soutenir la pratique clinique

Si vous êtes Médecin/Infirmier/Spécialiste, veuillez visiter MDBriefCase pour vous inscrire.

Si vous êtes Pharmacien, visitez RxBriefCase pour vous inscrire.

This 60-minute webinar is designed to provide Canadian HCPs with practical information on passive immunization options available in Canada, with a focus on the newly authorized long-acting monoclonal antibody nirsevimab, and the maternal RSVpref vaccine. The webinar will discuss RSV prevention through case studies, and highlight how a hospital order set can support implementation of the new RSV immunoprophylaxis in clinical practice.

Learning objectives:
Upon completion of this program, participants will be able to:

• Describe the prevalence and burden of RSV disease in all infants
• Summarize NACI guidance and supporting evidence on passive immunization for RSV
• Implement a hospital order set for RSV prevention to support clinical practice

Si vous êtes Médecin/Infirmier/Spécialiste, veuillez visiter MDBriefCase pour vous inscrire.

Si vous êtes Pharmacien, visitez RxBriefCase pour vous inscrire.

Ce programme « Expert en Bref » de 15 minutes s’adresse aux prestataires de soins primaires et aux autres professionnels de la santé au Québec. En raison du nombre limité d’options thérapeutiques disponibles pour prendre en charge la maladie due au VRS, l’objectif est d’offrir un enseignement sur la prévention de la maladie. Ce programme Expert en Bref a été conçu pour offrir des informations pratiques sur l’immunoprophylaxie contre le VRS disponible pour les nourrissons du Québec, en mettant l’accent sur les lignes directrices de l’INESSS et du MSSS pour l’usage du nirsévimab, un anticorps monoclonal à longue durée d’action récemment autorisé. La vidéo de ce programme présente une conversation entre une infirmière en soins néonataux et un médecin de famille.

Objectifs d'apprentissage :
Après avoir visionné cette vidéo « Expert en Bref », le participant sera mieux en mesure de :

• Reconnaître le fardeau que représente la maladie causée par le VRS chez tous les nourrissons
• Résumer les recommandations de l’INESSS/du MSSS pour l’immunoprophylaxie contre le VRS chez tous les nourrissons
• Mettre en œuvre l’immunoprophylaxie contre le VRS en contexte de pratique clinique

Si vous êtes Médecin/Infirmier/Spécialiste, veuillez visiter MDBriefCase pour vous inscrire.

Si vous êtes Pharmacien, visitez RxBriefCase pour vous inscrire.

Target Audience and Goal Statement

This activity is intended for obstetricians/gynecologists, primary care physicians, nurse practitioners, and nurses.

The goal of this activity is for learners to be better able to apply lessons learned from implementing novel maternal vaccines to prepare for emerging vaccines for congenital cytomegalovirus.

Upon completion of this activity, participants will:

• Have increased knowledge regarding the
• Importance of vaccination timing prior to pregnancy
• Challenges associated with vaccination prior to pregnancy
• Emerging vaccines to protect fetal health
• Have increased confidence in
• Effectively addressing vaccine-related misinformation and concerns among patients who are pregnant or planning on becoming pregnant

Pour vous inscrire, allez au site Internet de Medscape.

This 60-minute webinar will focus on the epidemiology, burden, and prevention of IMD, particularly in high-risk populations such as travellers, individuals attending mass gatherings, and older adults at risk. The session will highlight the importance of quadrivalent meningococcal conjugate vaccines and their role in preventing IMD in pre-travel consultations and geriatric consultations.

Learning objectives:
After completion of the webinar participants will be better able to:

• Describe the epidemiology and burden of invasive meningococcal disease (IMD)
• Differentiate quadrivalent conjugate meningococcal vaccines
• Evaluate clinical, safety, and administration data for the latest IMD vaccine (MenACWY-TT), including its immune response benefits and simplified administration
• Implement appropriate vaccination strategies for travellers and older adults at risk based on the latest evidence and guidelines

Si vous êtes Médecin/Infirmier/Spécialiste, veuillez visiter MDBriefCase pour vous inscrire.

Si vous êtes Pharmacien, visitez RxBriefCase pour vous inscrire.

Target Audience and Goal Statement

This educational activity is intended for an audience of primary care physicians, infectious disease specialists, and public health and preventative medicine specialists.

The goal of this activity is for learners to be better able to identify individuals at risk and how to communicate with potential recipients about the risk/benefit of chikungunya virus vaccines.

Upon completion of this activity, participants will:

• Have increased knowledge regarding the
  • Latest data on the burden of chikungunya disease
  • Data on chikungunya virus vaccines
• Have greater competence related to
  • Identifying who would benefit from the chikungunya vaccine

Pour vous inscrire, allez au site Internet de Medscape.

Target Audience and Goal Statement

This educational activity is intended for a global audience of primary care physicians, infectious disease specialists, public health and preventative medicine specialists, nurses, and pharmacists.

The goal of this activity is for learners to be better able to identify patients who are at risk for JEV infection, and be aware of the different Japanese encephalitis vaccines.

Upon completion of this activity, participants will:

• Have increased knowledge regarding the
  • Characteristics of JEV acquisition (eg, by < 1 month duration)
  • JEV vaccines
• Have greater competence in
  • Identifying travelers who are at risk of JEV

Pour vous inscrire, allez au site Internet de Medscape.

Après avoir achevé avec succès ce programme de formation continue, vous serez mieux en mesure de faire ce qui suit :

• décrire l’impact du changement climatique sur le risque de maladies transmises par les insectes au cours d’un voyage;
• expliquer l’épidémiologie, la présentation clinique, les résultats et les risques de maladies fréquemment transmises par les moustiques;
• définir les recommandations non pharmacologiques pour la protection contre les maladies transmises par les moustiques;
• examiner les différentes options vaccinales pour se protéger contre les différentes maladies transmises par les moustiques lors d’un voyage.

Leçon commanditée par un financement à visée éducative de Valneva.

Pour vous inscrire, allez au site Internet de eCortex.ca.

A rising number of Canadians are diagnosed with Lyme disease each year. This program aims to help clinicians effectively identify and treat Lyme disease in their patients. The program will review the clinical presentation and treatment of Lyme disease, with the overall goal of supporting clinicians in optimizingearly recognition and treatment of this condition.

Learning objectives:

Upon completion of this continuing education program, participants will be better able to:

• Describe the clinical presentation of Lyme disease
• Discuss appropriate treatment options for Lyme disease
• Advise patients on preventative measures for Lyme disease

Si vous êtes Pharmacien, visitez RxBriefCase pour vous inscrire.

Respiratory Syncytial Virus (RSV) represents a significant health threat to older adults, leading to severe respiratory complications and heightened mortality rates. This focused webinar explores the significant impact of RSV in older adults, the latest advancements in RSV vaccination, and practical strategies for integrating vaccination into clinical practice. This session will guide clinicians through understanding the current burden of RSV, comparing safety and efficacy data between available vaccines, and implementing the National Advisory Committee on Immunization’s (NACI) recommendations to optimize patient outcomes. Whether you’re looking to deepen your knowledge or refine your approach to patient care, this webinar will provide valuable insights and actionable strategies.

This program has received an unrestricted educational grant or in-kind support from Moderna Biopharm Canada Inc.

Learning objectives:

Upon completion of this webinar, participants will be better able to:

• Discuss the current NACI recommendations for RSV vaccination in older adults
• Compare the safety and efficacy data between available RSV vaccines for older adults
• Describe strategies to integrate RSV vaccination into clinical practice

Pour vous inscrire, allez au site Internet de mdBriefCase.

Target Audience and Goal Statement

This activity is intended for a Canadian audience of primary care physicians, obstetricians/gynecologists, oncologists, dentists, otolaryngologists, public and preventive health specialists, nurses, and pharmacists.

The goal of this activity is for learners to be better able to understand the challenges in human papillomavirus (HPV) vaccine uptake and key practical steps and communication triggers that are needed for successful HPV vaccine recommendation or administration.

Upon completion of this activity, participants will:

• Have increased knowledge regarding the Identification of expert recommended practical approaches to increase HPV vaccine uptake such as use of technology and patient engagement (eg, discussing link between virus and cancers)
• Demonstrate greater confidence in their ability to Effectively implement in daily practice communication to unvaccinated people regarding the benefits of HPV vaccination

Pour vous inscrire, allez au site Internet de Medscape.

The world has been living with COVID-19 for over 4 years. With the introduction of COVID-19 vaccines, it has been estimated that millions of cases, hospitalizations and deaths have been avoided globally. As the virus has continued to evolve, additional vaccine doses and updated vaccine formulations have been introduced to continue to provide protection from this virus. Canadians had one of the highest COVID-19 vaccine uptake in the world, with more than 4 out of 5 of the total population receiving at least 1 dose of a COVID-19 vaccine. With each subsequent dose, the uptake has been much lower, with only 16.3% of the total population receiving the last vaccine (XBB.1.5 formulation).

Pharmacists have been instrumental in vaccinating large portions of the community and providing information throughout the pandemic. With a new vaccine formulation being introduced in the fall, pharmacists will be relied upon to protect their patients and encourage vaccine uptake. This program is designed to provide pharmacists with a quick COVID-19 update, to allow them to provide them most current information for their patients.

Learning objectives:

Upon completion of this continuing education program, participants will be better able to:

• Summarize the current state of the COVID-19 pandemic and the role of pharmacists in vaccination
• Evaluate the effectiveness of the COVID-19 vaccine in preventing symptomatic disease and hospitalizations
• Explain the importance of coadministration of adult vaccines such as COVID-19 and influenza
• Formulate strategies to improve vaccine uptake in pharmacy patients

This program has received an educational grant or in-kind support from Moderna Biopharm Canada Inc.

Si vous êtes Médecin/Infirmier/Spécialiste, veuillez visiter MDBriefCase pour vous inscrire.

Si vous êtes Pharmacien, visitez RxBriefCase pour vous inscrire.